Clinical trials: Aggressive Behaviour
Aggression, Critical Care Staff
Intensive Care Unit Conflict Mediation Study
To evaluate the impact of a structured, multidisciplinary conflict management program incorporating an interprofessional Singular Care Plan *PAS* Committee and a Conflict Mediation Team on the incidence and severity of conflicts…
- Conditions
- Aggression, Critical Care Staff, Workplace Violence
- Trial name
- "GIRAFFE" (NCT07621874)
- Testing
- SEM DESTINO
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Hospital Israelita Albert Einstein
Non-Hodgkin Lymphoma
Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma
Although the cause(s) of clinical drug resistance in non-Hodgkin's lymphomas (NHL) are unknown, in vitro studies suggest that abnormalities of the cell cycle and mechanisms of apoptosis may play an important role.
- Trial name
- NCT00026910
- Where
- United States
- Volunteers
- 200 people
- Sponsor
- National Cancer Institute (NCI)
Aggression
Effect of Aggression Management Care Bundle
The aim of this sequential randomized controlled experimental design study is to develop an aggression care bundle approach in psychiatric care for patients with psychotic disorders, to use it in a psychiatric clinic, and to…
- Trial name
- NCT06661824
- Testing
- Aggression management care bundle
- Where
- Turkey (Türkiye)
- Volunteers
- 24 people
- Sponsor
- Abant Izzet Baysal University
Schizophrenia Disorder, Schizoaffecitve Disorder
A Virtual Reality Mindfulness Application for Aggression in Schizophrenia
The study investigates whether a virtual reality-based mindfulness based intervention can reduce impulsive aggression in individuals with schizophrenia or schizoaffective disorder.
- Conditions
- Schizophrenia Disorder, Schizoaffecitve Disorder, Aggression
- Trial name
- NCT07434479
- Testing
- Mindfulness-Based Virtual Reality Intervention
- Where
- 2 sites in United States
- Volunteers
- 58 people
- Sponsor
- Manhattan Psychiatric Center
Pancreatic Cancer
Dynamic PET acquisition-a Quantitative Technique for Grading of Malignant Tumors and Prediction of Response to Treatment
To assess a quantitative kinetic model of FDG uptake measurement using PET in patients with aggressive Non-Hodgkin's lymphoma and cancer of the pancreas, malignancies with known variability in disease aggressiveness and…
- Trial name
- NCT00294840
- Testing
- PET-CT
- Where
- Israel
- Volunteers
- 70 people
- Sponsor
- Rambam Health Care Campus
Non-Hodgkin's Lymphoma
Zevalin-beam for Aggressive Lymphoma
The study hypothesis is that the addition of zevalin radioimmunotherapy to the conditioning regimen given prior to BEAM high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive lymphoma will…
- Trial name
- NCT00491491
- Testing
- ibritumomab tiuxetan, BEAM chemotherapy and autologous stem-cell transplantation
- Where
- 9 sites in United States, Germany and 2 more
- Volunteers
- 60 people
- Sponsor
- Sheba Medical Center
Myocardial Infarction
Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI
The primary goal To assess the effect of atorvastatin in patients treated since the first 24-96 hours of the disease on the parameters of global and regional myocardial deformation in the infarcted area and the structural and…
- Trial name
- CONTRAST (NCT02590653)
- Testing
- Atorvastatin
- Where
- Russia
- Volunteers
- 200 people
- Sponsor
- Penza State University
Attention Deficit Disorder With Hyperactivity
Treatment of Severe Childhood Aggression (The TOSCA Study)
This study will determine the safety and effectiveness of two medications for treating aggression in children with attention deficit hyperactivity disorder (ADHD).
- Trial name
- NCT00796302
- Testing
- Methylphenidate HCl, Risperidone, Parent Management Training (PMT)
- Where
- 4 sites in United States
- Volunteers
- 168 people
- Sponsor
- Michael Aman
Appetitive Aggression
Addressing Heightened Levels of Aggression in Traumatized Offenders With Psychotherapeutic Means
Heightened levels of aggression are fuelling violent incidents at all levels, especially in post-war regions. Narrative Exposure Therapy for Forensic Offender Rehabilitation (FORNET) aims to address trauma symptoms along with…
- Trial name
- NCT02992561
- Testing
- FORNET (adapted version)
- Where
- Germany
- Volunteers
- 402 people
- Sponsor
- University of Konstanz
Non-Hodgkin's Lymphoma
Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma
This study investigates toxicity and efficacy of 2 x R-DHAP followed by High dose chemotherapy R-TEC and autologous stem cell transplantation in patients with relapsed or refractory aggressive Non- Hodgkins's Lymphoma.
- Trial name
- NCT00384553
- Testing
- Rituximab, DHAP, TEC
- Where
- Germany
- Volunteers
- 30 people
- Sponsor
- University of Magdeburg
Relapsing-Remitting Multiple Sclerosis
Ocrelizumab or Alemtuzumab Compared With Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis - a Phase-2 Randomised Controlled Trial
A multicentre controlled phase II trial to compare the efficacy and safety of ocrelizumab or alemtuzumab and autologous Hematopoietic Stem Cell Transplantation (aHSCT).
- Trial name
- COAST (NCT04971005)
- Testing
- Autologous Hematopoietic Stem Cell Transplantation, Ocrelizumab, Alemtuzumab
- Where
- 2 sites in Germany
- Volunteers
- 1 people
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
Aggression
Healthy Brains & Behavior: Understanding and Treating Youth Aggression
Understanding the joint neurobiological and social bases to aggression is critical to future attempts to tackle this major public health problem.
- Trial name
- HBB (NCT00842439)
- Testing
- CBI, NUT
- Where
- United States
- Volunteers
- 335 people, healthy volunteers welcome
- Sponsor
- University of Pennsylvania
B-cell Lymphomas With MYC Rearrangement
Safety and Efficacy of Intensified Chemotherapy Regimens in Aggressive B-cell Lymphomas With MYC Rearrangement
A multicenter, retrospective, observational drug study using anonymized data from adult patients with aggressive B-cell lymphoma treated with the CARMEN regimen.
- Trial name
- OSR-CARMEN (NCT07663175)
- Where
- Italy
- Volunteers
- 500 people
- Sponsor
- IRCCS San Raffaele
Aortic Disease
Dosing of Amicar and Measure of Fibrinolysis by TEG During Cardiac Surgery
This study hopes to determine the optimal antifibrinolytic dosing to decrease bleeding and blood transfusion after cardiac surgery without increasing adverse events
- Trial name
- EACA (NCT01965730)
- Testing
- epsilon-aminocaproic acid (EACA)
- Where
- United States
- Volunteers
- 8 people
- Sponsor
- University of Pennsylvania
Cyberbullying
Peer Group Training vs Direct Instruction to Reduce Cyberbullying Among High School Boys"
This study aims to explore ways to reduce cyberbullying among male high school students in Tehran by comparing two types of training: direct instruction from a psychologist and peer-led training.
- Trial name
- CyberPeer (NCT07204730)
- Testing
- Direct Social Skills Training, Peer-Led Social Skills Training, Control No Training
- Where
- Iran
- Volunteers
- 252 people, healthy volunteers welcome
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
Alzheimer's Disease, Alzheimer Dementia (AD)
Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia
The object of this study to evaluation an Integrated Care Pathway (ICP) to treat Aggression and Agitation in Alzheimer's disease (AD-AA).
- Conditions
- Alzheimer's Disease, Alzheimer Dementia (AD), Aggression
- Trial name
- StaN (NCT03672201)
- Testing
- Non-Pharmacological Intervention, Pharmacological Intervention
- Where
- 6 sites in Canada
- Volunteers
- 187 people
- Sponsor
- Centre for Addiction and Mental Health
Non-Hodgkin's Lymphoma
Allo-hNHL (FluBuCy)
DSHNHL R3 is a randomized clinical phase II study. The main objective is to estimate the efficacy of rituximab as a prophylactic medication for prevention of graft-versus-host-disease after allogeneic peripheral stem cell…
- Trial name
- NCT00785330
- Testing
- standard GVHD prophylaxis, rituximab
- Where
- 6 sites in Germany
- Volunteers
- 84 people
- Sponsor
- Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
Social Exclusion, Aggression
Motivational Interviewing-Based Training
The middle school period is the period when children begin to experience physical, emotional and social development and try to adapt to psychological changes.
- Conditions
- Social Exclusion, Aggression, Bullying of Child
- Trial name
- NCT06972030
- Testing
- Motivational interviewing
- Where
- Turkey (Türkiye)
- Volunteers
- 80 people
- Sponsor
- Muş Alparslan University
Skin Disease
Washing Without Water: Cost-effectiveness of a Rapidly Spreading Nursing Intervention in Bedridden Patients'
The purpose of this study is to compare the traditional bed bath with 'washing without water' on 1) effects on skin integrity 2) patient and nurse satisfaction and 3) costs.
- Trial name
- WWW (NCT01187732)
- Testing
- Washing without water
- Where
- Netherlands
- Volunteers
- 500 people
- Sponsor
- Betsie van Gaal
Central Giant Cell Granuloma
Efficacy of Nasal Spray Calcitonin on Recurrence of Aggressive Central Giant Cell Granuloma
The main objective of this randomised clinical trial is to is to compare the frequency of recurrence between patients who received nasal spray calcitonin after curettage of Central Giant Cell Granuloma and without it.
- Trial name
- NCT02358304
- Testing
- nasal spray calcitonin
- Where
- Iran
- Volunteers
- 24 people
- Sponsor
- Shiraz University of Medical Sciences